Rupee-led fears overblown; Opportunity to accumulate We believe the recent underperformance by Pharma sector stocks and fears of a further downside due to strengthening Rupee are unwarranted from a long-term perspective – Underlying exports growth in constant currency remains very robust; Rupee appreciation-led translation/transaction losses to be a one-year affair; Base effect to play out […]
READ MORE »